Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects

NCT07050316 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Neurologic Diseases, General

Interventions

DRUG: CBT101
DRUG: Placebo

Sponsor

Ceres Brain Therapeutics

Collaborators

[object Object]